PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 106 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 3.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $751,276 | -25.5% | 285,657 | +0.0% | 0.00% | -50.0% |
| Q2 2023 | $1,008,149 | +14.1% | 285,598 | -0.2% | 0.00% | 0.0% |
| Q1 2023 | $883,918 | -27.0% | 286,060 | -0.0% | 0.00% | -33.3% |
| Q4 2022 | $1,210,467 | +79.1% | 286,165 | +0.3% | 0.00% | +50.0% |
| Q3 2022 | $676,000 | -16.2% | 285,251 | +0.5% | 0.00% | 0.0% |
| Q2 2022 | $807,000 | -1.7% | 283,940 | -0.6% | 0.00% | 0.0% |
| Q1 2022 | $821,000 | -4.9% | 285,614 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $863,000 | -54.7% | 284,073 | +4.5% | 0.00% | -50.0% |
| Q3 2021 | $1,904,000 | -9.2% | 271,923 | +18.9% | 0.00% | -20.0% |
| Q2 2021 | $2,097,000 | +41.6% | 228,708 | +49.8% | 0.01% | +25.0% |
| Q1 2021 | $1,481,000 | -5.5% | 152,631 | -0.3% | 0.00% | 0.0% |
| Q4 2020 | $1,568,000 | -12.8% | 153,132 | -14.2% | 0.00% | -20.0% |
| Q3 2020 | $1,799,000 | +14.9% | 178,408 | +18.8% | 0.01% | 0.0% |
| Q2 2020 | $1,566,000 | +24.3% | 150,176 | +0.6% | 0.01% | 0.0% |
| Q1 2020 | $1,260,000 | -4.7% | 149,344 | -1.3% | 0.01% | +25.0% |
| Q4 2019 | $1,322,000 | +12.7% | 151,280 | +38.7% | 0.00% | +33.3% |
| Q3 2019 | $1,173,000 | +615.2% | 109,107 | +738.1% | 0.00% | +200.0% |
| Q2 2019 | $164,000 | -89.2% | 13,018 | -66.9% | 0.00% | -80.0% |
| Q1 2019 | $1,517,000 | +363.9% | 39,290 | +157.3% | 0.01% | +400.0% |
| Q4 2018 | $327,000 | +861.8% | 15,269 | +1919.7% | 0.00% | – |
| Q3 2018 | $34,000 | -95.6% | 756 | -94.2% | 0.00% | -100.0% |
| Q2 2018 | $771,000 | -35.0% | 13,049 | -25.2% | 0.00% | -40.0% |
| Q1 2018 | $1,187,000 | -27.5% | 17,447 | +5.3% | 0.01% | -16.7% |
| Q4 2017 | $1,638,000 | +539.8% | 16,575 | +674.5% | 0.01% | +500.0% |
| Q3 2017 | $256,000 | +573.7% | 2,140 | +326.3% | 0.00% | – |
| Q3 2015 | $38,000 | -90.3% | 502 | -85.1% | 0.00% | -100.0% |
| Q2 2015 | $393,000 | -59.6% | 3,367 | -18.2% | 0.00% | -50.0% |
| Q1 2015 | $972,000 | +49.8% | 4,117 | +20.0% | 0.01% | +33.3% |
| Q4 2014 | $649,000 | – | 3,432 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |